Statistical Evaluation of Surrogate Endpoints in Clinical Studies

doi 10.1201/b17716-25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Chapman and Hall/CRC

Related search

A Perspective on Surrogate Endpoints in Controlled Clinical Trials

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2004English

Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

PLoS ONE
Multidisciplinary
2017English

Surrogate Endpoints for Efficacy in Clinical Research: Working Definitions and Validation

AACR Education book
2008English

Abstracts of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
1998English

Surrogate Endpoints in Advanced Sarcoma Trials: A Meta-Analysis

Oncotarget
Oncology
2018English

Perioperative Management of ACE Inhibitor Therapy: Challenges of Clinical Decision-Making Based on Surrogate Endpoints

Journal of Hospital Medicine
Internal MedicineCare PlanningHealth PolicyFundamentalsSkillsLeadershipManagementDiagnosisMedicineAssessment
2018English

Uncertainty in the Bayesian Meta-Analysis of Normally Distributed Surrogate Endpoints

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2015English

Surrogate and Intermediate Endpoints in Randomized Trials: What's the Goal?

Clinical Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy